Author Fietkau, R.

• 2017 | Journal Article
  ​ ​PV-0325: Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma​
  Fokas, E.; Ghadimi, M. ; Fietkau, R.; Ströbel, P. ; Hartmann, A.; Sauer, R. & Liersch, T.  et al.​ (2017) 
  Radiotherapy and Oncology, 123 pp. S170​-S171​.​ DOI: https://doi.org/10.1016/S0167-8140(17)30767-3 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial​
  Fokas, E.; Fietkau, R.; Hartmann, A.; Hohenberger, W.; Grützmann, R.; Ghadimi, M.   & Liersch, T.  et al.​ (2018) 
  Annals of Oncology, 29(7) pp. 1521​-1527​.​ DOI: https://doi.org/10.1093/annonc/mdy143 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial​
  Hofheinz, R.-D.; Arnold, D.; Fokas, E.; Kaufmann, M. ; Hothorn, T.; Folprecht, G. & Fietkau, R. et al.​ (2018) 
  Annals of Oncology, 29(8) pp. 1793​-1799​.​ DOI: https://doi.org/10.1093/annonc/mdy205 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​OC-0278: NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial​
  Fokas, E.; Fietkau, R.; Hartmann, A.; Hohenberger, W.; Grützmann, R.; Ghadimi, M.   & Liersch, T.  et al.​ (2018) 
  Radiotherapy and Oncology, 127 pp. S142​.​ DOI: https://doi.org/10.1016/S0167-8140(18)30588-7 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​OC-0384 QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04)​
  Kosmala, R.; Fokas, E.; Flentje, M.; Sauer, R.; Liersch, T. ; Graeven, U. & Fietkau, R. et al.​ (2019) 
  Radiotherapy and Oncology, 133 pp. S191​-S192​.​ DOI: https://doi.org/10.1016/S0167-8140(19)30804-7 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial​
  Fokas, E.; Allgäuer, M.; Polat, B.; Klautke, G.; Grabenbauer, G.; Fietkau, R. & Kuhnt, T. et al.​ (2019) 
  Radiotherapy and Oncology, 133 pp. S257​-S258​.​ DOI: https://doi.org/10.1016/S0167-8140(19)30921-1 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​OC-0499 Neutrophilia as prognostic factor for outcome in the CAO/ARO/AIO-04 phase 3 rectal cancer trial​
  Diefenhardt, M.; Hofheinz, R.; Arnold, D.; Müller von den Grün, J.; Liersch, T. ; Ströbel, P.   & Grabenbauer, G. et al.​ (2019) 
  Radiotherapy and Oncology, 133 pp. S256​-S257​.​ DOI: https://doi.org/10.1016/S0167-8140(19)30919-3 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial​
  Wittel, U. A.; Lubgan, D.; Ghadimi, M. ; Belyaev, O.; Uhl, W.; Bechstein, W. O. & Grützmann, R. et al.​ (2019) 
  BMC Cancer, 19(1).​ DOI: https://doi.org/10.1186/s12885-019-6148-5 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial​
  Fietkau, R.; Grützmann, R.; Wittel, U. A.; Croner, R. S.; Jacobasch, L.; Neumann, U. P. & Reinacher-Schick, A. et al.​ (2020) 
  Strahlentherapie und Onkologie, 197(1) pp. 8​-18​.​ DOI: https://doi.org/10.1007/s00066-020-01680-2 
  ​Details  DOI 

• 2021 | Conference Abstract
  ​ ​Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Final results of the CAO/ ARO/ AIO-12 randomized phase 2 trial​
  Fokas, E.; Schlenska-Lange, A.; Polat, B.; Klautke, G.; Grabenbauer, G.; Fietkau, R. & Kuhnt, T. et al.​ (2021)
  Strahlentherapie und Onkologie, 197(Suppl. 1) pp. S7​-S8. ​27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie​, virtuell.
  ​Details 

• 2021 | Conference Abstract
  ​ ​TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial​
  Fokas, E.; Schlenska-Lange, A.; Polat, B.; Klautke, G.; Fietkau, R.; Kuhnt, T. & Brunner, T. et al.​ (2021)
  Radiotherapy and Oncology, 161(Suppl. 1) pp. S199​-S200. ​CARO 2021, Transforming Care in Radiation Medicine​, virtual.
  ​Details  WoS 

Researcher

Sort

Items per Page